Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations.
Is Intracerebral Hemorrhage Risk Shared via Blood Transfusion?
Recipients of red blood cell transfusions from donors who later had multiple intracerebral hemorrhages (ICHs) had a significantly increased risk of spontaneous ICH themselves, an
September 13, 2023